International Journal of Cancer Management
The Official Journal of Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences
OpenAlex
Works that cite this article, indexed by OpenAlex.
The Molecular Mechanisms That Underlie the Immune Biology of Anti-drug Antibody Formation Following Treatment With Monoclonal Antibodies
Frontiers in Immunology 11 (2020)
Anna Vaisman‐Mentesh; Matías Gutiérrez-González; Brandon J. DeKosky; Yariv Wine
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
CNS Drugs 35(9) (2021)
Amit Bar‐Or; Susan Mary O'Brien; Michael L. Sweeney; Edward J. Fox; Jeffrey A. Cohen
Development of anti-rituximab antibodies in rituximab-treated patients: Related parameters & consequences
International Journal of Microbiology Research 155(3&4) (2022)
Fatemeh Saffari; Abdollah Jafarzadeh
Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside
Journal of Pharmaceutical Sciences 110(7) (2021)
Katharine M. Bray; Katharina Hartman; Guido Steiner; Céline Marban-Doran; Juliana Bessa; Neil Campbell; Meret Martin‐Facklam; Kay‐Gunnar Stubenrauch; Corinne Solier; Thomas Singer; Axel Ducret
Anti-drug antibodies in the current management of cancer
Cancer Chemotherapy and Pharmacology 89(5) (2022)
Miguel Borregón; Katherine Martínez; Alba Ramos; Irene Ramos; Beatriz Berzal; Manuel Mazariegos; Elia Martínez; Tatiana Hernández; Bernard Doger; Víctor Moreno
Anti-rituximab antibodies in patients with refractory autoimmune nodopathy with anti-neurofascin-155 antibody
Frontiers in Immunology 14 (2023)
Yunfei Bai; Wěi Li; Chuanzhu Yan; Ying Hou; Qinzhou Wang